The Correlation of PBK Expression with an Immune-Activated Tumor Microenvironment and Outcome in Colorectal Cancer
Authors:
- Hiroshi SawaguchiHSHiroshi Sawaguchi
- Takeshi UeharaTUTakeshi Uehara
- Mai IwayaMIMai Iwaya
- Shiho AsakaSAShiho Asaka
- Tomoyuki NakajimaTNTomoyuki Nakajima
- Shotaro KomamuraSKShotaro Komamura
- Shunsuke ImamuraSIShunsuke Imamura
- Yugo IwayaYIYugo Iwaya
- Shinsuke SugenoyaSSShinsuke Sugenoya
- Masato KitazawaMKMasato Kitazawa
- Yuji SoejimaYSYuji Soejima
- Hiroyoshi OtaHOHiroyoshi Ota
Open Access
Abstract
Background/Objectives: PDZ-binding kinase (PBK) regulates mitosis, but its clinical significance and cellular localization in colorectal cancer (CRC) remain unclear. We evaluated PBK expression in CRC tissues and examined its association with clinicopathological features, immune contexture, and outcomes. Methods: PBK expression was assessed by RNA in situ hybridization in tumors from 246 CRC patients. Associations with TNM stage, vascular invasion, MMR status (dMMR/pMMR), immune cell infiltration, and stromal programmed death-ligand 1 (PD-L1) were analyzed. Overall survival (OS) and recurrence-free survival (RFS) were evaluated using Kaplan–Meier and Cox models. Public single-cell RNA sequencing datasets were analyzed to identify PBK-expressing cell populations. Results: Among 246 cases, 75 (30.5%) showed high PBK expression. High PBK expression was associated with lower TNM stage, absence of vascular invasion, and dMMR status. High-PBK tumors showed an immune-activated microenvironment, including increased CD4+, CD8+, and FOXP3+ T-cell infiltration, higher stromal PD-L1 expression, and higher tumor-infiltrating lymphocyte scores. Single-cell analysis indicated that PBK expression was enriched mainly in proliferative tumor epithelial cell populations. High PBK expression was associated with longer OS and RFS and remained an independent favorable prognostic factor in multivariate analysis. Conclusions: PBK expression in CRC is linked to proliferative tumor epithelial states, an immune-activated microenvironment, and favorable outcomes, supporting its utility as a prognostic biomarker.Keywords
This publication has 44 references indexed in Scilit:
- High INHBB Expression Shapes an Immunosuppressive Tumor Microenvironment and Predicts Poor Prognosis in Colorectal CarcinomaDigestive Diseases and Sciences, 2025
- TOPK Inhibition Enhances the Sensitivity of Colorectal Cancer Cells to Radiotherapy by Reducing the DNA Damage ResponseCurrent Medical Science, 2024
- RNAscope compatibility with image analysis platforms for the quantification of tissue-based colorectal cancer biomarkers in archival formalin-fixed paraffin-embedded tissueActa Histochemica, 2021
- PBK expression predicts favorable survival in colorectal cancer patientsVirchows Archiv, 2021
- Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysisInternational Journal of Colorectal Disease, 2020
- Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasisCancer Letters, 2019
- Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer PatientsClinical Colorectal Cancer, 2019
- Fully Automated RNAscope In Situ Hybridization Assays for Formalin‐Fixed Paraffin‐Embedded Cells and TissuesJournal of Cellular Biochemistry, 2016
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal CarcinomaCell Reports, 2016
- Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancerThe Journal of Pathology, 1997